Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Role of miRNAs induced by oxidized low-density lipoproteins in coronary artery disease: the REGICOR Study

IR Dégano, I Subirana, N García-Mateo, P Cidad, D Muñoz-Aguado, E Puigdecanet, L Nonell, J Vila, A Camps, F Crepaldi, D de Gonzalo-Calvo, Vc Llorente-Cortés, MT Pérez-García, R Elosua, M Fitó, J Marrugat
doi: https://doi.org/10.1101/19003749
IR Dégano
aREGICOR Study Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
cFaculty of Medicine, University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I Subirana
aREGICOR Study Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
dCIBER Epidemiology and Public Health, ISCIII, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N García-Mateo
eDepartment of Biochemistry, molecular biology, and physiology, Institute of Molecular Biology and Genetics (IBGM), University de Valladolid, Spanish National Research Council (CSIC), Valladolid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P Cidad
eDepartment of Biochemistry, molecular biology, and physiology, Institute of Molecular Biology and Genetics (IBGM), University de Valladolid, Spanish National Research Council (CSIC), Valladolid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D Muñoz-Aguado
fCardiovascular Risk and nutrition Group, IMIM, Barcelona, Spain
gCIBER of Obesity and Nutrition (CIBEROBN), ISCIII, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E Puigdecanet
cFaculty of Medicine, University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain
hMARGenomics, IMIM, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L Nonell
hMARGenomics, IMIM, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Vila
aREGICOR Study Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
dCIBER Epidemiology and Public Health, ISCIII, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A Camps
aREGICOR Study Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F Crepaldi
aREGICOR Study Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D de Gonzalo-Calvo
iCardiovascular Research Center, CSIC-ICCC, IBB-Sant Pau, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vc Llorente-Cortés
iCardiovascular Research Center, CSIC-ICCC, IBB-Sant Pau, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MT Pérez-García
eDepartment of Biochemistry, molecular biology, and physiology, Institute of Molecular Biology and Genetics (IBGM), University de Valladolid, Spanish National Research Council (CSIC), Valladolid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R Elosua
bCIBER of Cardiovascular Diseases (CIBERCV), Instituto de Salud Carlos III (ISCIII), Madrid, Spain
cFaculty of Medicine, University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain
iCardiovascular Research Center, CSIC-ICCC, IBB-Sant Pau, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M Fitó
fCardiovascular Risk and nutrition Group, IMIM, Barcelona, Spain
gCIBER of Obesity and Nutrition (CIBEROBN), ISCIII, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Marrugat
aREGICOR Study Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
bCIBER of Cardiovascular Diseases (CIBERCV), Instituto de Salud Carlos III (ISCIII), Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jmarrugat@imim.es iroman@imim.es
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Aims Current risk prediction tools are not accurate enough to identify most individuals at high coronary risk. On the other hand, oxidized low-density lipoproteins (ox-LDLs) and miRNAs are actively involved in atherosclerosis. Our aim was to examine the association of ox-LDL-induced miRNAs with coronary artery disease (CAD), and to assess their predictive capacity of future CAD.

Methods and results Human endothelial and vascular smooth muscle cells were treated with oxidized or native LDLs (nLDL), and their miRNA expression was measured with the miRNA 4.0 array, and analyzed with moderated t-tests. Differently expressed miRNAs and others known to be associated with CAD, were examined in serum samples of 500 acute myocardial infarction (AMI) patients and 500 healthy controls, and baseline serum of 117 incident CAD cases and c 485 randomly-selected cohort participants (case-cohort). Both were developed within the REGICOR AMI Registry and population cohorts from Girona. miRNAs expression in serum was measured with custom OpenArray plates, and analyzed with fold change (age and sex-paired case-control) and survival models (case-cohort). Improvement in discrimination and reclassification by miRNAs was assessed. Twenty-one miRNAs were up- or down-regulated with ox-LDL in cell cultures. One of them, 1 (has-miR-122-5p, fold change=4.85) was upregulated in AMI cases. Of the 28 known CAD-associated miRNAs, 11 were upregulated in AMI cases, and 1 (hsa-miR-143-3p, hazard ratio=0.56 [0.38-0.82]) was associated with CAD incidence and improved reclassification.

Conclusion We identified 2 novel miRNAs associated with ox-LDLs (hsa-miR-193b-5p and hsa-miR-1229-5p), and 1 miRNA that improved reclassification of healthy individuals (hsa-miR-143-3p).

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the Spain’s Ministry of Science and Innovation through the Carlos III Health Institute, co-financed with European Union ERDF funds [INTRASALUD PI11/01801, PI15/00064, Network for Prevention and Health Promotion in primary Care RedIAPP RD06/0018, RD12/0005, CIBERCV CB16/11/00229, CIBERESP CB06/02/0029, CIBEROBN CB06/03/0028]; by the BBVA Foundation [PR-16-BIO-CAR-0041] by the Health Departament of the Generalitat de Catalunya, through the Agency for Health Quality and Assessment of Catalonia (AQUAS) and the Strategic Plan for research and health innovation (PERIS) [SLT002/16/ 00145, SLT006/17/00029], and by the Catalan Agency for Management of University and Research Grants (AGAUR) [2017 SGR 222].

Author Declarations

All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.

Not Applicable

I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.

Yes

Data Availability

The data used in this study is available from the authors on reasonable request

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted August 02, 2019.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Role of miRNAs induced by oxidized low-density lipoproteins in coronary artery disease: the REGICOR Study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Role of miRNAs induced by oxidized low-density lipoproteins in coronary artery disease: the REGICOR Study
IR Dégano, I Subirana, N García-Mateo, P Cidad, D Muñoz-Aguado, E Puigdecanet, L Nonell, J Vila, A Camps, F Crepaldi, D de Gonzalo-Calvo, Vc Llorente-Cortés, MT Pérez-García, R Elosua, M Fitó, J Marrugat
medRxiv 19003749; doi: https://doi.org/10.1101/19003749
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Role of miRNAs induced by oxidized low-density lipoproteins in coronary artery disease: the REGICOR Study
IR Dégano, I Subirana, N García-Mateo, P Cidad, D Muñoz-Aguado, E Puigdecanet, L Nonell, J Vila, A Camps, F Crepaldi, D de Gonzalo-Calvo, Vc Llorente-Cortés, MT Pérez-García, R Elosua, M Fitó, J Marrugat
medRxiv 19003749; doi: https://doi.org/10.1101/19003749

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Cardiovascular Medicine
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (50)
  • Cardiovascular Medicine (448)
  • Dentistry and Oral Medicine (80)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (190)
  • Epidemiology (5219)
  • Forensic Medicine (3)
  • Gastroenterology (195)
  • Genetic and Genomic Medicine (750)
  • Geriatric Medicine (77)
  • Health Economics (212)
  • Health Informatics (694)
  • Health Policy (352)
  • Health Systems and Quality Improvement (223)
  • Hematology (99)
  • HIV/AIDS (162)
  • Infectious Diseases (except HIV/AIDS) (5823)
  • Intensive Care and Critical Care Medicine (356)
  • Medical Education (102)
  • Medical Ethics (25)
  • Nephrology (80)
  • Neurology (758)
  • Nursing (43)
  • Nutrition (129)
  • Obstetrics and Gynecology (141)
  • Occupational and Environmental Health (231)
  • Oncology (475)
  • Ophthalmology (149)
  • Orthopedics (38)
  • Otolaryngology (94)
  • Pain Medicine (39)
  • Palliative Medicine (19)
  • Pathology (139)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (854)
  • Public and Global Health (1995)
  • Radiology and Imaging (345)
  • Rehabilitation Medicine and Physical Therapy (157)
  • Respiratory Medicine (283)
  • Rheumatology (93)
  • Sexual and Reproductive Health (72)
  • Sports Medicine (75)
  • Surgery (108)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)